Phase I pharmacokinetic study of etmaben, a malonic acid derivative

Phase I pharmacokinetic study of etmaben, a malonic acid derivative

Introduction. Etmaben is a malonic acid derivative that has shown cardiotropic activity and is a promising candidate for treating ischemic heart disease and chronic heart failure. It is currently undergoing Phase I clinical trials, and its pharmacokinetics have not yet been studied in humans.Aim. Th...

Full description

Saved in:

Bibliographic Details
Main Authors:	P. K. Karnakova, K. K. Karnakova, T. N. Komarov, N. S. Bagaevа, M. O. Popova, D. Yu. Ivkin, O. A. Archakova, I. E. Shohin, I. A. Narkevich
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2024-11-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	4-[(3-ethoxy-3-oxopropanoyl)amino]benzoic acid pharmacokinetics cardiovascular diseases ischemic heart disease drug development
Online Access:	https://www.pharmjournal.ru/jour/article/view/1986
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and Validation of an HPLC-MS/MS Method for the Quantitative Determination of Etmaben in Human Blood Plasma
by: P. K. Karnakova, et al.
Published: (2024-03-01)

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial
by: T. N. Komarov, et al.
Published: (2024-03-01)

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01)

Development and validation of a high-performance liquid chromatography with tandem mass spectrometry method for quantification of tofacitinib in human plasma
by: E. S. Vetrova, et al.
Published: (2024-06-01)

Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2023-05-01)

Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma
by: U. D. Filonova, et al.
Published: (2024-03-01)

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01)

Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC "Pharmcenter VILAR", Russia)
by: O. A. Archakova, et al.
Published: (2022-02-01)

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma
by: T. N. Komarov, et al.
Published: (2022-09-01)

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-05-01)

Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS
by: P. K. Karnakova, et al.
Published: (2021-11-01)

Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV
by: P. A. Karpova, et al.
Published: (2022-05-01)

Methyl 3-[(tert-butoxycarbonyl)amino]benzoate
by: Murugesan Ponmagaram, et al.
Published: (2025-06-01)

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-02-01)

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-09-01)

Synthesis and biological activity of arylheteraaliphatic amino amides
by: А. I. Ivanova, et al.
Published: (2015-02-01)

Sclerotherapy for dilated veins of atypical localization
by: V. Yu. Bogachev, et al.
Published: (2018-12-01)

3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate
by: Rosalba Leuci, et al.
Published: (2024-08-01)

The Study of [3H]-Cycloprolylglycine Pharmacokinetics in Rat Blood
by: G. I. Kovalev, et al.
Published: (2019-10-01)

Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease
by: N. A. Shatalova, et al.
Published: (2023-11-01)

The potential corrosion inhibition properties of acetyl benzoic acid derivatives with substituted alkali metals (Na, K, Li): DFT approach
by: Rebaz Obaid Kareem, et al.
Published: (2025-06-01)

Enhancing overcharge cycling endurance of lithium-ion batteries via a multifunctional electrolyte
by: Yutao Liu, et al.
Published: (2025-06-01)

Organizing of pharmacokinetic investigations
by: I. I. Miroshnichenko, et al.
Published: (2022-02-01)

Evaluation of Pharmacokinetical Parameters of Phenol, a Component of Antiseptic Dorogov's stimulator 3 Fraction Paste
by: V. I. Nozdrin, et al.
Published: (2019-09-01)

Liposomes – metabolically active drug transport systems: visualization and pharmacokinetic. Part 2 (review)
by: O. N. Pozharitskaya, et al.
Published: (2024-11-01)

Discovery of novel favipiravir derivatives with improved pharmacokinetic properties as anti-SFTSV agents
by: Xiaomeng He, et al.
Published: (2024-12-01)

Analysis of sparse data in pharmacokinetic studies
by: I. I. Miroshnichenko, et al.
Published: (2020-12-01)

Determination of Lappaconitin, Diterpene Alkaloide Obtained from Plants <i>Aconitum leucostomum</i>, and its Active Metabolite N-desacetyllappaconitin in Human Plasma and Blood
by: O. A. Archakova, et al.
Published: (2021-08-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

Determination of QLNC-3A6 in canine plasma by UHPLC-MS/MS and its application in pharmacokinetic studies
by: Sumeng Chen, et al.
Published: (2024-12-01)

Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models
by: Jing Han, et al.
Published: (2025-02-01)

Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study
by: Fei Y, et al.
Published: (2025-05-01)

Investigation of pharmacokinetics and immunogenicity of magnetosomes
by: M. Haripriyaa, et al.
Published: (2024-12-01)

Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation
by: Alexandra D. Ladd, et al.
Published: (2025-07-01)

Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)
by: T. I. Smolyanova, et al.
Published: (2022-05-01)

Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study [Corrigendum]
by: Fei Y, et al.
Published: (2025-06-01)

A Natural Compound Methylnissolin: Physicochemical Properties, Pharmacological Activities, Pharmacokinetics and Resource Development
by: Lin Z, et al.
Published: (2025-05-01)

Biosynthesis of three benzoic acid derivatives in Escherichia coli
by: Hyun-Ah Kim, et al.
Published: (2025-08-01)

Sex Differences on the Pharmacokinetics of Drugs for Children with Chronic Kidney Disease: A Narrative Review
by: Toktam Faghihi, et al.
Published: (2024-10-01)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
by: Luisa Oliveira Santos, et al.
Published: (2024-08-01)